Last Updated:
Name Designation Appointment Date Status
Suresh Nagappa Ganachari

Appointed as Director since November 2022

Director 28-Nov-2022 Current
Premium access

Complete director details

Unlock the complete director and KMP records available for Recipharm Holding India Private Limited.

  • Complete appointment and designation records
  • Current and past company associations
  • Shareholding and remuneration where filed

Verified entity values are shown only after access is granted.

Emmanuel Nicolas Grand

Appointed as Director since January 2023

Director 06-Jan-2023 Current
Daniela Schalko

Appointed as Additional Director since January 2025

Additional Director 28-Jan-2025 Current

People Timeline

Explore the timeline of key personnel in Recipharm Holding India Private Limited's leadership journey.

Loading...
Contact Details
  • Address Flat No. 502, B Wing, Building No. 48,, Tilak Indrayani Housing Society, Tilak Nagar (W), Chembur,, Mumbai Maharashtra, 400089, India
  • Telephone Upgrade
  • Email Upgrade
Frequently Asked Questions
You can contact Recipharm Holding India Private Limited through their registered address at Flat No. 502, B Wing, Building No. 48,, Tilak Indrayani Housing Society, Tilak Nagar (W), Chembur,, Mumbai Maharashtra, 400089, India, or via their website at recipharm.com. Social media links are also provided where applicable.
The current directors of Recipharm Holding India Private Limited are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • SURESH NAGAPPA GANACHARI
  • EMMANUEL NICOLAS GRAND
  • Daniela Schalko
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available